PT Asuransi Bina Dana Arta Tbk (ISX:ABDA) Research & Development: Rp0 Mil (TTM As of Mar. 2026)


ISX:ABDA PT Asuransi Bina Dana Arta Tbk ISX:ABDA
63 GF Score
Price Rp3,310.00
GF Value Rp5,009.40
Valuation Significantly Undervalued
! 1 Warning Sign
View Full Analysis

What is PT Asuransi Bina Dana Arta Tbk Research & Development?

PT Asuransi Bina Dana Arta Tbk ISX:ABDA 63 Research & Development is Rp0 Mil as of Mar. 2026. GuruFocus rates ISX:ABDA with a GF Score™ of 63/100 and a GF Value™ of Rp5,009.40 (Significantly Undervalued). The stock has 1 warning sign investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. PT Asuransi Bina Dana Arta Tbk's Research & Development for the three months ended in Mar. 2026 was Rp0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was Rp0 Mil.

PT Asuransi Bina Dana Arta Tbk  (ISX:ABDA) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

PT Asuransi Bina Dana Arta Tbk Research & Development Related Terms

PT Asuransi Bina Dana Arta Tbk Research & Development Historical Data

* Premium members only.

The historical data trend for PT Asuransi Bina Dana Arta Tbk's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT Asuransi Bina Dana Arta Tbk Research & Development Chart

PT Asuransi Bina Dana Arta Tbk Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

PT Asuransi Bina Dana Arta Tbk Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
ISX:ABDA
63GF Score
PT Asuransi Bina Dana Arta Tbk ISX:ABDA
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PT Asuransi Bina Dana Arta Tbk Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was Rp0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of Rp0 Mil mean?
PT Asuransi Bina Dana Arta Tbk (ISX:ABDA) has a Research & Development of Rp0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on PT Asuransi Bina Dana Arta Tbk and its competitors.
Is PT Asuransi Bina Dana Arta Tbk's Research & Development too high?
PT Asuransi Bina Dana Arta Tbk's current Research & Development is Rp0 Mil. Overall, PT Asuransi Bina Dana Arta Tbk has a GF Score™ of 63/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PT Asuransi Bina Dana Arta Tbk's Research & Development compare to CB and PGR?
PT Asuransi Bina Dana Arta Tbk's Research & Development of Rp0 Mil can be compared against companies in the Insurance industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for an Insurance company?
A good Research & Development depends on the Insurance industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on PT Asuransi Bina Dana Arta Tbk and its competitors. PT Asuransi Bina Dana Arta Tbk's current Research & Development is Rp0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Asuransi Bina Dana Arta Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Asuransi Bina Dana Arta Tbk (ISX:ABDA) is currently considered Significantly Undervalued. The stock's GF Value™ is Rp5,009.40, compared to a current price of Rp3,310.00 — trading 33.9% below its estimated fair value. The current Research & Development is Rp0 Mil. PT Asuransi Bina Dana Arta Tbk's overall GF Score™ is 63/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For PT Asuransi Bina Dana Arta Tbk (ISX:ABDA), the current Research & Development is Rp0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PT Asuransi Bina Dana Arta Tbk (ISX:ABDA) Overvalued in 2026?

Based on GuruFocus' analysis, PT Asuransi Bina Dana Arta Tbk stock appears to be undervalued. The current stock price of Rp3,310.00 is trading 33.9% below its estimated GF Value™ of Rp5,009.40. GuruFocus considers PT Asuransi Bina Dana Arta Tbk to be Significantly Undervalued.

Key valuation signals for ISX:ABDA:

  • Research & Development: Rp0 Mil
  • GF Value™: Rp5,009.40 vs. price of Rp3,310.00 (33.9% below fair value)
  • GF Score™: 63/100 with 1 warning sign

No single metric tells the full story. See the ISX:ABDA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

PT Asuransi Bina Dana Arta Tbk Business Description

Address Jalan Jenderal Sudirman Kav. 59, RT. 5 RW. 3, Plaza Asia, 27th Floor, Senayan, Kec. Kebayoran Baru, South Jakarta, Jakarta, IDN, 12190
PT Asuransi Bina Dana Arta Tbk is an Indonesian-based insurance service provider. It provides insurance services protection against any losses, such as fire, vehicles, engineering, liability, transportation, heavy equipment and machinery, health protection, and others. The company generates the majority of the premium revenue from the Motor vehicle insurance services it provides. Geographically, the group operations in Indonesia are carried out in Sumatra and Batam, Kalimantan, Jawa, Sulawesi, Bali, and Greater Jakarta, of which key revenue is derived from Greater Jakarta.
63GF Score

Get the complete analysis for ISX:ABDA

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Rp3,310.00
Price
Rp5,009.40
GF Value